The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abivax SA COMM 00370M103   11,770,000 1,100,000 SH   SOLE   1,100,000 0 0
AEROVATE THERAPEUTICS INC COMM 008064107   49,814,831 2,201,274 SH   SOLE   2,201,274 0 0
AN2 Therapeutics, Inc. COMM 037326105   54,876,502 2,678,209 SH   SOLE   2,678,209 0 0
C4 THERAPEUTICS, INC. COMM 12529R107   7,212,643 1,276,574 SH   SOLE   1,276,574 0 0
CABALETTA BIO, INC COMM 12674W109   11,050,247 486,795 SH   SOLE   486,795 0 0
CENTESSA PHARMACEUTICALS PLC COMM 152309100   16,244,895 2,040,816 SH   SOLE   2,040,816 0 0
COGENT BIOSCIENCES INC COMM 19240Q201   33,110,527 5,631,042 SH   SOLE   5,631,042 0 0
COMPASS PATHWAYS PLC ADRS 20451W101   33,757,500 3,858,000 SH   SOLE   3,858,000 0 0
DYNE THERAPEUTICS, INC COMM 26818M108   21,946,995 1,650,150 SH   SOLE   1,650,150 0 0
ENTRADA THERAPEUTICS INC COMM 29384C108   8,826,971 584,955 SH   SOLE   584,955 0 0
GERON CORP COMM 374163103   49,323,020 23,375,839 SH   SOLE   23,375,839 0 0
GRACELL BIOTECHNOLOGIES INC. ADRS 38406L103   45,328,451 4,514,786 SH   SOLE   4,514,786 0 0
ICOSAVAX INC COMM 45114M109   58,370,375 3,703,704 SH   SOLE   3,703,704 0 0
INHIBRX,INC COMM 45720L107   66,514,706 1,750,387 SH   SOLE   1,750,387 0 0
KALVISTA PHARMACEUTICALS, INC COMM 483497103   41,594,814 3,395,495 SH   SOLE   3,395,495 0 0
KODIAK SCIENCES INC COMM 50015M109   814,540 267,941 SH   SOLE   267,941 0 0
KURA ONCOLOGY INC COMM 50127T109   20,471,972 1,423,642 SH   SOLE   1,423,642 0 0
MADRIGAL PHARMACEUTICALS INC COMM 558868105   41,629,195 179,917 SH   SOLE   179,917 0 0
NURIX THERAPEUTICS INC COMM 67080M103   7,406,189 717,654 SH   SOLE   717,654 0 0
RAYZEBIO, INC. COMM 75525N107   54,082,180 869,908 SH   SOLE   869,908 0 0
SAVARA INC. COMM 805111101   47,000,000 10,000,000 SH   SOLE   10,000,000 0 0
SILENCE THERAPEUTICS PLC ADRS 82686Q101   36,561,679 2,104,875 SH   SOLE   2,104,875 0 0
STRUCTURE THERAPEUTICS INC ADRS 86366E106   85,986,644 2,109,584 SH   SOLE   2,109,584 0 0
TARSUS PHARMACEUTICALS, INC. COMM 87650L103   23,142,854 1,142,857 SH   SOLE   1,142,857 0 0
TAYSHA GENE THERAPIES, INC. COMM 877619106   5,155,764 2,912,861 SH   SOLE   2,912,861 0 0
TOURMALINE BIO INC COMM 89157D105   26,386,874 1,007,902 SH   SOLE   1,007,902 0 0
TYRA BIOSCIENCES INC COMM 90240B106   27,549,077 1,989,103 SH   SOLE   1,989,103 0 0
VENTYX BIOSCIENCES, INC COMM 92332V107   2,014,838 815,724 SH   SOLE   815,724 0 0
VISTAGEN THERAPEUTICS INC COMM 92840H202   13,757,621 2,676,580 SH   SOLE   2,676,580 0 0